BBNX
Beta Bionics·NASDAQ
--
--(--)
--
--(--)
2.38 / 10
Underperform
With an aggregate technical rating of 2.38/10, the stock exhibits challenging technical structure. Favorable signals from no significant factors are partially offset by weaknesses in Long Upper Shadow and MACD Golden Cross. The technical profile supports a cautious stance.
Analysis Checks(0/2)
Long Upper Shadow
Score1.73/10
Win Rate43.14%
Hist. Signals51
Avg Return-0.47%
Score1.73/10
Win Rate43.14%
Hist. Signals51
Avg Return-0.47%
MACD Golden Cross
Score3.03/10
Win Rate42.86%
Hist. Signals7
Avg Return0.67%
Score3.03/10
Win Rate42.86%
Hist. Signals7
Avg Return0.67%
Long Upper Shadow
Score1.73/10
Win Rate43.14%
Hist. Signals51
Avg Return-0.47%
Score1.73/10
Win Rate43.14%
Hist. Signals51
Avg Return-0.47%
MACD Golden Cross
Score3.03/10
Win Rate42.86%
Hist. Signals7
Avg Return0.67%
Score3.03/10
Win Rate42.86%
Hist. Signals7
Avg Return0.67%
What is the current technical signals for BBNX?
- BBNX presents a Underperform setup with a Technical Score of 2.38/10. Key technical indicators highlight an RSI of 23.19 and a MACD of 0.15, with the trend anchored by the 50-Day SMA at 24.51. Traders should monitor key support at 12.72 and resistance at 14.21.
